Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective

Table 4 Results: Benefits for the hospital

	Consequences of Mydrane® introduction
Total number of operations gained	36.81
Total additional revenue (£)	27,412
Total expected net benefit (£)	11,733

ISSN: 1471-2415